552 related articles for article (PubMed ID: 11205904)
1. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
2. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
3. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin.
Wong WW; Tan MM; Xia Z; Dimitroulakos J; Minden MD; Penn LZ
Clin Cancer Res; 2001 Jul; 7(7):2067-75. PubMed ID: 11448925
[TBL] [Abstract][Full Text] [Related]
4. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
5. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.
Agarwal B; Bhendwal S; Halmos B; Moss SF; Ramey WG; Holt PR
Clin Cancer Res; 1999 Aug; 5(8):2223-9. PubMed ID: 10473109
[TBL] [Abstract][Full Text] [Related]
6. Mevalonate prevents lovastatin-induced apoptosis in medulloblastoma cell lines.
Wang W; Macaulay RJ
Can J Neurol Sci; 1999 Nov; 26(4):305-10. PubMed ID: 10563217
[TBL] [Abstract][Full Text] [Related]
7. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
Swamy MV; Cooma I; Reddy BS; Rao CV
Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
[TBL] [Abstract][Full Text] [Related]
8. Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas.
Dimitroulakos J; Marhin WH; Tokunaga J; Irish J; Gullane P; Penn LZ; Kamel-Reid S
Neoplasia; 2002; 4(4):337-46. PubMed ID: 12082550
[TBL] [Abstract][Full Text] [Related]
9. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
[TBL] [Abstract][Full Text] [Related]
10. Strategies to enhance epidermal growth factor inhibition: targeting the mevalonate pathway.
Dimitroulakos J; Lorimer IA; Goss G
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4426s-4431s. PubMed ID: 16857822
[TBL] [Abstract][Full Text] [Related]
11. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
Cuthbert JA; Lipsky PE
Cancer Res; 1997 Aug; 57(16):3498-505. PubMed ID: 9270019
[TBL] [Abstract][Full Text] [Related]
12. Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach.
Dimitroulakos J; Nohynek D; Backway KL; Hedley DW; Yeger H; Freedman MH; Minden MD; Penn LZ
Blood; 1999 Feb; 93(4):1308-18. PubMed ID: 9949174
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
[TBL] [Abstract][Full Text] [Related]
14. Diosgenin, a naturally occurring steroid [corrected] saponin suppresses 3-hydroxy-3-methylglutaryl CoA reductase expression and induces apoptosis in HCT-116 human colon carcinoma cells.
Raju J; Bird RP
Cancer Lett; 2007 Oct; 255(2):194-204. PubMed ID: 17555873
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the HMG-CoA reductase inhibitor lovastatin and nitric oxide in cardiomyocyte cell death.
Rabkin SW; Tsang MY
Pharmacology; 2008; 82(1):74-82. PubMed ID: 18504415
[TBL] [Abstract][Full Text] [Related]
16. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
Hoque A; Chen H; Xu XC
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
[TBL] [Abstract][Full Text] [Related]
17. Abolition of mevinolin-induced growth inhibition in human fibroblasts following transformation by simian virus 40.
Larsson O; Barrios C; Latham C; Ruiz J; Zetterberg A; Zickert P; Wejde J
Cancer Res; 1989 Oct; 49(20):5605-10. PubMed ID: 2551491
[TBL] [Abstract][Full Text] [Related]
18. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
19. d-δ-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells.
Hussein D; Mo H
Pancreas; 2009 May; 38(4):e124-36. PubMed ID: 19346993
[TBL] [Abstract][Full Text] [Related]
20. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
